Evidence map›Paper›PMID 37240059›Full record

ArticleInternational journal of molecular sciences2023

Detection of Elevated Level of Tetrahydrobiopterin in Serum Samples of ME/CFS Patients with Orthostatic Intolerance: A Pilot Study.

Carl Gunnar Gottschalk, Ryan Whelan, Daniel Peterson, Avik Roy

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06257420 (Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06257420 enrolling by invitationnot on this map

Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions

TypeobservationalSponsorSimmaron Research Inc.Ran2023 to 2027Enrolled150ConditionsMyalgic Encephalomyelitis, Long-COVIDArmsRapamycin
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Carl Gunnar GottschalkSimmaron Research Institute, 948 Incline Way, Incline Village, NV 89451, USA.ORCID 0000-0003-4229-2542
Ryan WhelanSimmaron Research Institute, 948 Incline Way, Incline Village, NV 89451, USA.
Daniel PetersonSimmaron Research Institute, 948 Incline Way, Incline Village, NV 89451, USA.
Avik RoySimmaron Research Institute, 948 Incline Way, Incline Village, NV 89451, USA.
Sierra Nevada College · US

Funding

Fondation de Sibylla Hesse NA
6 · The paper itself

Abstract

Myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) is a multisystem chronic illness characterized by severe muscle fatigue, pain, dizziness, and brain fog. Many patients with ME/CFS experience orthostatic intolerance (OI), which is characterized by frequent dizziness, light-headedness, and feeling faint while maintaining an upright posture. Despite intense investigation, the molecular mechanism of this debilitating condition is still unknown. OI is often manifested by cardiovascular alterations, such as reduced cerebral blood flow, reduced blood pressure, and diminished heart rate. The bioavailability of tetrahydrobiopterin (BH4), an essential cofactor of endothelial nitric oxide synthase (eNOS) enzyme, is tightly coupled with cardiovascular health and circulation. To explore the role of BH4 in ME/CFS, serum samples of CFS patients (

Indexed as

Fatigue Syndrome, ChronicOrthostatic IntoleranceBiopterinsDizzinessHumansPilot ProjectsBiopterinssapropterinendothelial NOSME/CFSorthostatic intolerancereactive oxygen speciessmall fiber polyneuropathytetrahydrobiopterin

Identifiers

PMID37240059
PMCPMC10218672
OpenAlexW4376614802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.